@prefix this: . @prefix sub: . @prefix drugbank: . @prefix np: . @prefix pav: . @prefix infores: . @prefix hp: . @prefix xsd: . @prefix ntemplate: . @prefix orcid: . @prefix rdfs: . @prefix pmid: . @prefix ncit: . @prefix rdf: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { drugbank:DB00704 a biolink:Drug; rdfs:label "Naltrexone"; biolink:category biolink:Drug . hp:000098 a biolink:Disease; rdfs:label "pruritus"; biolink:category biolink:Disease . sub:association rdf:object hp:000098; rdf:predicate biolink:treats; rdf:subject drugbank:DB00704; a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; rdfs:label "Off-label use includes treatment of cholestatic pruritus in adults."; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; biolink:has_population_context sub:context; biolink:publications pmid:30521232; biolink:relation ncit:C94303 . sub:context a biolink:Cohort; rdfs:label "Adults"; biolink:category biolink:Cohort . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB"; npx:hasSignature "ckS3r8891sMj2O6qVWunqCDLMvuvZqFLEB+0BFP/vPyuwzdDrwsJH1ETKK+wD32QQqJVys4DWpNm4OeOhCyglqIyMTQy/rARldh9e/SWFSJJsDGuDX4ZTemI6pU3ks7yfJYSCVtxjPTw0PVEEq23eN8kDqDni5C9z1o3sO+i+Gk="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-09-16T11:46:37.706545"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-1501-1082; ntemplate:wasCreatedFromTemplate . biolink: pav:version "2.3.0" . }